S

symplr

Healthcare operations software and credentialing services

Senior Financial Analyst - Product & Delivery Financial Planning and Analysis

Full-TimeUpdated on 10/14/2026Deadline 10/9/27
$100k - $120k/yr
Senior
Bachelor's
United States
In Person
Finance & BankingCorporate Finance & FP&A

About the job

Requirements
  • Strong financial modeling, analytical, critical-thinking, and problem-solving skills, with the ability to integrate multiple functional models into a consolidated company view.
  • Strong understanding of income-statement relationships, forecasting, budgeting, long-range planning, variance analysis, and financial scenario modeling.
  • Excellent written and verbal communication and business-partnering skills, including the ability to explain model results to technical and non-technical stakeholders and work effectively across FP&A, Accounting, and business leadership.
  • Advanced proficiency in Excel and experience working with financial planning platforms.
  • Strong organizational and documentation skills, including model governance, assumption tracking, metric definitions, and process documentation.
  • Ability to manage multiple priorities and recurring deliverables in a fast-paced environment, with strong attention to detail and an understanding of broader business and financial implications.
  • Bachelor’s degree in Finance, Accounting, Economics, Business Analytics, or a related field.
  • 5+ years of relevant experience in FP&A, corporate finance, financial modeling, or a related analytical role.
  • Demonstrated experience building or maintaining consolidated P&L forecasts and financial models.
  • Experience consolidating inputs from multiple functions, business units, or operating models.
  • Experience supporting annual budgets, rolling forecasts, long-range plans, and scenario-planning processes.
  • Experience defining, calculating, or governing company-level financial and operating metrics.
  • Experience providing FP&A support to business functions and their leaders.
Responsibilities
  • Own and continuously improve the company’s consolidated financial model, integrating validated functional assumptions and model outputs across revenue, gross margin, labor, operating expenses, EBITDA, and other material financial measures into the forecast, annual budget, and long-range plan.
  • Partner with FBP teams to capture, understand, and consolidate functional models and forecasts, including revenue, Professional Services, CVO, Product labor, and other operating models.
  • Maintain clear links and reconciliations among functional models, the consolidated P&L model, reported actuals, and executive reporting, partnering with Accounting to resolve material differences.
  • Evaluate functional plans for internal consistency and identify cross-functional dependencies, gaps, duplicate assumptions, conflicting inputs, risks, opportunities, and management actions.
  • Develop scenario and sensitivity analyses that translate changes in functional drivers into consolidated P&L outcomes and actionable recommendations.
  • Support the Monthly Reporting Package and executive reporting by providing consolidated financial analysis, KPI reporting, validated model outputs, company-level scenarios, and key risks and opportunities.
  • Analyze department-level variances and collaborate with FBPs to connect functional explanations to consolidated financial impacts.
  • Support the Finance Business Partner for designated functions, including budgeting, forecasting, monthly analysis, headcount and purchase-request review, business cases, ad hoc decision support, and recommendations to functional leaders.
  • Partner with systems resources and external consultants to document and implement approved consolidation logic, model connections, and metric calculations within the planning environment.
  • Establish and maintain model documentation, assumption tracking, data-validation controls, and governance standards, while identifying opportunities to automate recurring consolidations, reconciliations, scenario analyses, and KPI reporting.
  • Present financial findings, scenarios, implications, and recommendations clearly to FP&A leadership and other stakeholders.
  • Facilitate FP&A’s ownership of final executive deliverables and the consolidated financial narrative by providing validated consolidated outputs, metrics, scenarios, and analytical support.
  • Perform other duties and projects as assigned.
Desired Qualifications
  • Working knowledge of data-querying, analytics, and visualization tools.
  • Experience in a SaaS or other subscription-based business.
  • Experience in a private equity-backed environment.
  • Familiarity with planning systems such as Adaptive and BI tools such as Power BI.
  • Experience working with ERP, CRM, business intelligence, or financial data sources.

About the company

Symplr provides enterprise healthcare operations software and services to hospitals to simplify administrative tasks. Its Symplr Operations Platform unifies multiple operations tools via shared services and APIs to automate and connect workflows across facilities. Core products include Symplr Access for secure facility access and vendor check-ins with high compliance, and Symplr CVO for provider credentialing and payer enrollment, reducing admin workload. The platform aims to reduce administrative burden and improve clinical and financial outcomes by offering an integrated, compliant workflow solution across a large network of hospitals.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$311M

Headquarters

Houston, Texas

Founded

2006

Get referred to symplr

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • February 2026 ViVE launches added AI scheduling, contract redlining, and vendor access tools.
  • March 18, 2026 ShiftMed integrated with Smart Square, expanding real-time clinician fulfillment.
  • June 29, 2026 CFO Andrew Langford and April 13 CEO Venkat Kavarthapu strengthened execution.

What critics are saying

  • September 2026 refinancing confirms distress: $175 million preferred equity and $103.5 million debt.
  • First-lien debt matures in 2027; nonparticipants get subordinated, crushing recovery value.
  • AI-driven workflow commoditization threatens symplr's software moat and recapitalization fails without lender support.

What makes symplr unique

  • Symplr sits in nine of 10 U.S. hospitals, embedding itself deeply into operations.
  • Its Operations Platform unifies workforce, access, contracts, and provider data across workflows.
  • Smart Square won Best in KLAS in 2025 and 2026 for scheduling.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours
  • Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

3%
PR Newswire
Oct 6th, 2026
Symplr secures $280M refinancing to extend debt maturities and support healthcare software growth

Symplr, a healthcare operations software provider, has secured commitment letters for a refinancing transaction that will extend debt maturities and provide approximately $280 million in new capital. The deal, expected to close by end of October, extends the company's first-lien term loan and revolving credit facility to December 2030, whilst second-lien term loans mature in June 2031. The refinancing includes substantial new investment from sponsors Clearlake Capital Group and Charlesbank Capital Partners. The transaction aims to enhance liquidity, reduce near-term cash interest requirements, and provide greater financial flexibility for the company's growth strategy. Chief executive Venkat Kavarthapu said the refinancing creates additional runway to execute strategy and invest in the business. Symplr's platform serves nine of 10 US hospitals and over 400 health plans.

MTS Partners
Sep 25th, 2026
Healthcare technology & tech-enabled services week in review: 10/2/2026.

Healthcare technology & tech-enabled services week in review: 10/2/2026. Healthcare technology & tech-enabled services week in review: 9/25/2026. September 25, 2026. Key highlights from this week include: * Angle Health, an AI-powered healthcare benefits platform, raised $600mm in equity financing including a $200mm Series C financing round and a $400mm tender offer led by Vitruvian Partners at a $2.7bn valuation * Heidi, an AI-powered care partner platform, received a $240mm growth investment from General Catalyst concurrent with a $100mm Series C financing round led by Blackbird at a $900mm valuation * Symplr, a healthcare operations software platform, received a $175mm preferred equity investment from existing sponsors Clearlake Capital and Charlesbank Capital Partners as part of a broader recapitalization * Rightway, a pharmacy benefits and care navigation company, raised $155mm in a Series E financing round led by Francisco Partners * Blackstone-backed Ascend Learning acquired M7 Health, an AI-powered clinical scheduling and workforce management platform * Ardan Equity made a strategic investment in Clinical Ink, a clinical trials software provider, alongside existing investor GI Partners at a $400mm valuation

GFM Limited
Sep 22nd, 2026
Clearlake and Charlesbank to inject $175m into distressed Symplr.

Clearlake and Charlesbank to inject $175m into distressed Symplr. * September 22, 2026 * - 10:34 am Private equity firms Clearlake Capital Group and Charlesbank Capital Partners have agreed to provide around $175m of preferred equity to healthcare software provider Symplr as part of a restructuring designed to shore up the company's finances and push out debt maturities, according to a report by Bloomberg. The report cites unnamed people familiar with the matter as revealing that the sponsors have reached an agreement with several groups of creditors on the proposed recapitalisation and are seeking wider lender support. Under the terms being discussed, Clearlake and Charlesbank will defer interest payments on newly issued junior-ranking debt, helping Symplr preserve cash as it works through its financial challenges. Separately, second-lien lenders are expected to provide $103.5m of additional financing through a first-out second-lien loan. The facility would rank ahead of existing second-lien debt and would be available to other junior-ranking creditors. The restructuring follows months of negotiations between Symplr and its lenders as the company's debt has traded at distressed levels amid broader concerns about the impact of artificial intelligence on the software sector. Symplr's debt has faced particular pressure. Its loans were among the largest markdowns recorded by an Ares private credit fund during the first quarter, while Moody's Ratings downgraded Symplr and its debt further into junk territory in July, citing an increased risk of restructuring. As part of the proposed transaction, existing second-lien lenders would receive a 100-basis-point increase in their coupon. The debt would carry a combination of cash interest and payment-in-kind interest, according to people familiar with the terms. Holders of Symplr's first-lien term loan, which matures in 2027, would also receive a 100-basis-point coupon increase in return for extending the maturity by three years. The revised loan documentation would include stronger protections for participating lenders. Creditors that choose not to take part in the proposed exchange would be pushed to the bottom of Symplr's capital structure and lose certain covenant protections. Symplr's approximately $1.2bn first-lien term loan was recently quoted at about 71.4 cents on the dollar, compared with around 78 cents in early March and 86.5 cents at the beginning of January. Its nearly $290m second-lien term loan, due in 2028, was recently quoted at about 70 cents. Symplr is held through a continuation vehicle containing the healthcare software company as its sole asset, according to a 2022 company announcement. Representatives for Clearlake, Charlesbank and Ares Capital reportedly declined to comment, while Symplr reportedly did not respond to requests for comment.

Mint
Sep 21st, 2026
Symplr secures $175M equity injection and $103.5M loan from PE backers amid restructuring

Symplr Software's private equity backers, Clearlake Capital Group and Charlesbank Capital Partners, have agreed to inject approximately $175 million of preferred equity into the distressed healthcare software provider. The restructuring deal includes multiple debt securities and extended repayment timelines. Second-lien lenders, including Ares Capital Corp., will provide $103.5 million in fresh funding structured as a first-out second-lien loan. Clearlake and Charlesbank have agreed to defer interest payments on new junior-ranking debt to conserve cash. The deal follows months of negotiations after concerns about artificial intelligence's impact hit software companies earlier this year. Symplr's roughly $1.2 billion first-lien term loan recently traded at 71.4 cents on the dollar, down from 86.5 cents in January. Existing lenders will receive 100-basis-point coupon increases in exchange for extending maturities.

PR Newswire
Jun 29th, 2026
symplr appoints Andrew Langford as CFO to drive AI-powered healthcare innovation

symplr, a healthcare operations software provider backed by Clearlake Capital Group and Charlesbank Capital Partners, has appointed Andrew Langford as chief financial officer. Langford brings extensive experience in finance leadership, strategic transformation and mergers and acquisitions. Previously, Langford served as executive vice president at Zelis, overseeing financial strategy, treasury and operational planning. He also spent nearly a decade at Global Payments in senior finance roles, with significant experience in investor relations and growth strategy across the Americas and Europe. As CFO, Langford will oversee financial planning, accounting, treasury, investor relations and M&A functions. He succeeds Tom Fink, who served as interim CFO since early 2026. The appointment comes as symplr scales its investment in AI-powered innovation for healthcare operations.